TERN vs TXN · $6.12B cap vs P/E 52, rev $17.68B
Terns Pharmaceuticals Inc (TERN) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
TERN currently screens at market cap $6.12B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the TERN and TXN stock pages for the full models.
Not investment advice.